- Home
- JAZZ vs WMS Comparison
JAZZ vs WMS Comparison
Compare JAZZ & WMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAZZ
- WMS
- Stock Information
- Founded
- JAZZ 2003
- WMS 1966
- Country
- JAZZ Ireland
- WMS United States
- Employees
- JAZZ N/A
- WMS N/A
- Industry
- JAZZ Biotechnology: Pharmaceutical Preparations
- WMS Containers/Packaging
- Sector
- JAZZ Health Care
- WMS Consumer Discretionary
- Exchange
- JAZZ Nasdaq
- WMS Nasdaq
- Market Cap
- JAZZ 8.1B
- WMS 9.7B
- IPO Year
- JAZZ 2007
- WMS 2014
- Fundamental
- Price
- JAZZ $136.01
- WMS $114.38
- Analyst Decision
- JAZZ Strong Buy
- WMS Strong Buy
- Analyst Count
- JAZZ 14
- WMS 8
- Target Price
- JAZZ $177.50
- WMS $164.25
- AVG Volume (30 Days)
- JAZZ 688.4K
- WMS 670.6K
- Earning Date
- JAZZ 02-25-2025
- WMS 02-06-2025
- Dividend Yield
- JAZZ N/A
- WMS 0.56%
- EPS Growth
- JAZZ 458.10
- WMS N/A
- EPS
- JAZZ 7.04
- WMS 5.98
- Revenue
- JAZZ $3,992,712,000.00
- WMS $2,942,324,000.00
- Revenue This Year
- JAZZ $7.53
- WMS $2.98
- Revenue Next Year
- JAZZ $6.94
- WMS $6.28
- P/E Ratio
- JAZZ $19.42
- WMS $19.16
- Revenue Growth
- JAZZ 5.23
- WMS 3.67
- 52 Week Low
- JAZZ $99.06
- WMS $110.75
- 52 Week High
- JAZZ $138.27
- WMS $184.27
- Technical
- Relative Strength Index (RSI)
- JAZZ 68.46
- WMS 36.48
- Support Level
- JAZZ $134.56
- WMS $122.20
- Resistance Level
- JAZZ $138.27
- WMS $128.71
- Average True Range (ATR)
- JAZZ 3.56
- WMS 4.65
- MACD
- JAZZ 1.17
- WMS -0.67
- Stochastic Oscillator
- JAZZ 88.20
- WMS 12.00
About JAZZ Jazz Pharmaceuticals plc (Ireland)
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
About WMS Advanced Drainage Systems Inc.
Advanced Drainage Systems Inc is engaged in designing, manufacturing, and marketing thermoplastic corrugated pipe and related water management products in North and South America, and Europe. The company's operating segment includes Pipe; Infiltrator; International and Allied Products and Other. It generates maximum revenue from the Pipe segment. The company serves Agriculture; Aviation and Military; Mining; Residential; Transportation; Healthcare and Education and others.